학술논문
Ⅰ, Ⅱ기 악성 림프종 환자의 방사선 치료 성적
이용수 14
- 영문명
- Result of Radiation Therapy for Stage Ⅰ, Ⅱ Non-Hodgkin's Lymphoma
- 발행기관
- 대한방사선종양학회
- 저자명
- 이규찬 (Kyuchan Lee) 김철용 (Chul Yong Kim) 최명선 (Myung Sun CHoi)
- 간행물 정보
- 『대한방사선종양학회지』제11권 제1호, 159~166쪽, 전체 8쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1993.06.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
A retrospective analysis was done for 69 patients with stage Ⅰ and Ⅱ non-Hodgkin's lymphoma who were treated form May 1981 to December 1990, in the Department of Radiadtion Oncology, Korea University Hospital. We used Ann Arbor Staging system and working Formulation for histological classification. Forty-three patients (43/69, 62.3%) were Stage Ⅰ and 26 patients (26/69, 37.7%) were stage Ⅱ, and B symptom was found in 10.1% (7/69).
Nodal lymphoma was 21.7% (15/69); 14 patients with supradiaphragmatic disease and 1 patient with infradiaphragmatic disease. Extranodal lymphoma was 78.3% (54/69); 64.8% (35/54) for head and neck, 25.9% (14/54) for gastrointestinal tract. Histologically, low grade consists of 8.7% (6/69), intermediate grade 84.2% (56/69), high grade 10.1% (7/69), and diffuse large cell type was the most frequent form with 36 patients (36/69, 52.2%).
Eighteen patients (26.1%) were treated with radiation therapy alone, 20 patients (29.0%) with radiation therapy combined with chemotherapy, 15 patients (21.7%) with radiation therapy combined with surgery and chemotherapy.
Median survival duration was 28 months, and the range of survival time was form 1 month to 134 months, overall five-year survival rate for Stage Ⅰ and Ⅱ disease was 54.2%, with 64.5% for Stage Ⅰ and 37.1% for Stage Ⅱ, For nodal lymphoma, 5-year survival rate was 45.9%, and 56.5% for extranodal lymphoma; 60.6% for head and neck, 52.9% for GI track primary disease.
Local control rate for all patients was 88.4% (61/69), with 80% (12/15) for nodal lymphoma and 90.7% (49/54) for extranodal lymphoma. The total failure rate was 34.8% (24/69). Five of 24 (20.8%) patients who were failed developed local failure only, 12.5% (3/24) local failure with distant failure, and distant failure only were found in 66.7% (16/24). Between nodal lymphoma and extranodal lymphoma, there was no significant survival difference, but extranodal lymphoma showed higher incidence.
목차
abstract
서론
대상 및 방법
결과
고찰
결론
REFERENCES
해당간행물 수록 논문
- 비인강암 환자의 고선량 강내 방사선 치료의 효과
- 진행된 원발성 간암 환자에서 방사선 치료 및 온열 요법에 따른 간 기능의 변화
- [삭제] IBM Personal Computer를 이용한 3차원적 뇌정위 방사선 수술계획 시스템의 개발
- 수술 불가능한 췌장암 환자에서 방사선 치료의 역할
- 동시 간 전이가 있는 직장암 환자에서 원발 부위에 대한 수술 후 보조 방사선 치료의 역할
- 6 MV 광자선의 투과성필터와 Wedge 선속을 이용한 부비강의 균등선량계획
- Ⅰ, Ⅱ기 악성 림프종 환자의 방사선 치료 성적
- Postoperative Radiation Therapy of Craniopharyngioma
- Dosimetry and Three Dimensional Planning for Stereotactic Radiosurgery with SIEMENS 6-MV LINAC
- Sequence and Time Interval in Combination of Irradiation and Cis-Diamminedichloroplatinum in C3H Mouse Fibrosarcoma
- 직장암의 방사선 치료결과 및 실패양상
- 자궁경부암 ⅢB 기의 방사선치료 성적
- The Results of Radiation Therapy of Limited Stage Small Cell Lung Cancer
- 다형성 세망증(Polymorphic Reticulosis)의 방사선 치료 성적
- 수술불능 및 재발성 직장암에 대한 중성자선 치료
- Combined Effects of Gamma-irradiation and Hyperthermia on the Human Cell Lines for Various Temperatures and Time Sequences
- IBM Personal Computer를 이용한 3차원적 뇌정위 방사선 수술계획 시스템의 개발
- Result of Radiation Therapy of Cerebellar Medulloblastoma
- 인체 상피암 세포주에서 방사선감수성과 손상회복의 상관관계에 관한 연구
- Preliminary Results of Management for Primary CNS Lymphoma
- Frequency of Micronuclei in Lymphocytes Following Gamma and Fast-neutron Irradiations
- Effect of Radiotherapy on Chromosomal Aberration in Cancer Patients
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- 두경부암에서 면역회피 기전과 면역항암제 치료
의약학 > 종양학분야 NEW
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!